sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > MAPK Signaling > ERK > VX-11e
VX-11e  
Catalog No. T3166    CAS 896720-20-0
Pack Size
Availability
Price/USD
Quantity
2mg
In stock
56.00
5mg
In stock
101.00
10mg
In stock
147.00
25mg
In stock
264.00
50mg
In stock
419.00
100mg
In stock
651.00
1 mL * 10 mM (in DMSO)
In stock
130.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:98.92% COA Datasheet HNMR HPLC
Biological Activity:

Product Description:

VX-11e is a potent, selective, and orally bioavailable ERK(Extracellular Signal-Regulated Kinase) inhibitor; antitumor agent.

Target:
ERK;
Research Area:
Cancer
Chemical Information:
Molecular Weight 500.35
Formula C24H20Cl2FN5O2
CAS Number 896720-20-0
Solubility DMSO:50 mg/mL (100 mM);Ethanol:12.5 mg/mL (25 mM)
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • Avapritinib, Avapritinib is a dual inhibitor of the mutant KIT receptor (KIT D816V, IC50: 0.27 nM) and PDGFRα (PD...
  • LY3200882, LY3200882 is a highly selective inhibitor of TGF-β receptor type 1 (TGFβRI).
  • Alofanib, Alofanib is a selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect on FGF2-i...
  • GDC-0810, GDC-0810 is a selective estrogen receptor degrader (IC50: 0.7 nM).
  • CPI-203, CPI-203 is an effective BET bromodomain inhibitor (IC50: 37 nM for BRD4).

 

Reference

If you have additional questions, Please send us a message. * Required